Fig. 1From: Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptinRelationship between time-matched QTcP changes from baseline and saxagliptin (a) and 5-hydroxy saxagliptin (b) plasma concentrations. Data points above the horizontal lines indicate time-matched QTcP change from baseline values >30 ms or 60 msBack to article page